AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_48_IL-23 and MMP-9 as predictors of adverse course of psoriasis and NAFLD comorbiditiesView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_47_Impact of Treating Hyperuricemic NAFLD Patients with Allopurinol on Cytokeratin 18: A Pilot StudyView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_46_Correction of portohepatic hemodynamics disorders and increased ammonia by ornithine at the non-alcoholic steatohepatitis patients without cirrhosisView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_45_Devenir au long cours des patients traités par analogues nucléot(s)idiques pour cirrhose virale B à l’Hôpital Principal de DakarView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_44_Clinical and laboratory predictors of mortality in patients hospitalized for liver cirrhosis in CameroonView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_43_Plasminogen Activator Inhibitor Type 1 in Liver Cirrhosis Patients and Non-Alcoholic Steatohepatitis under the Influence of Treatment with Human Albumin InfusionView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_42_Hepatic Resection for Hepatocelullar Carcinoma in Nigeria: a Sigle Centre Experiece from Northwest NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_41_Risks of developing hepatocellular carcinoma in patients with chronic HCV-infectionView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_39_Outcomes of Sorafenib therapy for hepatocellular carcinoma in EthiopiaView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_40_Possible Role of Natural Killer Cells in Hepatitis C Virus Related Hepatocellular CarcinomaView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_37_Prevalence de l’AgHBs et l’AcHCV chez les hemodialyses : cas de l’hopital general de Yaounde, CamerounView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_38_High HIV Viremia is associated with Increased Risk of Liver Cancers among poorly Viral Suppressed ART Initiators in South Western NigeriaView Abstract
